FIA
EDSA icon

FNY Investment Advisers’s Edesa Biotech EDSA Stock Holding History

FNY Investment Advisers’s Portfolio EDSA Stock Details EDSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-234
Closed -$12K – 618
2021
Q3 		$12K Buy
+234
New +$9.11K 0.01% 527
2021
Q1 		– Sell
-10,714
Closed -$318K – 842
2020
Q4 		$318K Sell
10,714
-6,487
-38% -$265K 0.09% 166
2020
Q3 		$971K Buy
+17,201
New +$819K 0.41% 65

Other funds holding EDSA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

FNY Investment Advisers's EDSA Position: Q4 2021 in Review

FNY Investment Advisers sold out of Edesa Biotech (EDSA) in Q4 2021, closing a stake of 234 shares — an estimated $12K sold.

FNY Investment Advisers first reported a position in EDSA in Q3 2020 and held it in 3 quarters. The position peaked at $971K in Q3 2020. 25 funds tracked by Wall St. Rank hold EDSA as of Q4 2021.

  • FNY Investment Advisers reported no remaining Edesa Biotech position as of Q4 2021 after selling out during the quarter.
  • FNY Investment Advisers sold 234 Edesa Biotech shares in Q4 2021, an estimated $12K.
  • FNY Investment Advisers first reported a position in Edesa Biotech in Q3 2020 and held it in 3 quarters.
  • FNY Investment Advisers's Edesa Biotech position peaked at $971K in Q3 2020.
  • 25 funds tracked by Wall St. Rank held Edesa Biotech as of Q4 2021.

Based on FNY Investment Advisers's 13F filing for Q4 2021, filed 10 Jan 2022.